Aim. To study the role of imaging technologies in reclassifying cardiovascular risk (CVR) and choosing management strategies for asymptomatic patients. Material and methods. A total of 137 asymptomatic patients aged ≥40 years (men, 85,4%; mean age, 52,0±7,2 years) were examined. The Systematic Coronary Risk Evaluation 2 (SCORE2) was used to determine the risk of cardiovascular disease. All patients were assessed for coronary calcium score (CCS), the condition of the carotid (extracranial artery Doppler ultrasound) and coronary (coronary computed tomography angiography (CCTA)) arteries. In addition, glomerular filtration rate were estimated with subsequent CVR restratification. Results. Depending on the CCS, patients were divided into following groups: group 1 — 78 (56,9%) patients with CCS of 0 (median age, 50,0 (44,0; 53,0) years; men, 83,3%); group 2 included 59 patients (43,1%) with CCS >0, median, 87,0 (16,5; 187,0); median age, 53,0 (49,0; 59,0) years; men, 88,1%. CCS determination, extracranial artery Doppler ultrasound, CCTA allowed for risk reclassification in 28 patients (20,4%): 10 patients (12,8%) in group 1 and 18 patients (30,5%) with a CCS >0 in group 2. In 2,9% of patients, the estimated glomerular filtration rate increased the CVR class. Risk reclassification based on imaging led to pharmacotherapy adjustments. Conclusion. Supplementing the traditional SCORE2 with imaging techniques (CCS, CCTA, extracranial artery Doppler ultrasound) improves the CVR class in asymptomatic patients, enabling personalized primary prevention of cardiovascular events.